Understanding TH9507 in people affected with HIV lipodystrophy
Wednesday, September 3, 2008 - 09:42
in Health & Medicine
Thousands of HIV patients have similar stories with regards to their body morphology. Whether attributed to lipathophy (localized loss of fat tissue) as described by Dr. Robles patient or lipohypertrophy (abnormal central fat accumulation) which has similar prevalence patterns. TH9507 a growth hormone promoter may show promise in reducing the symptoms associated with lipodystrophy in the near future. read more